Mr Andrew D PriceMr. Andrew D. Price

ADP EyeCare



Mrs Vanessa Uden Mrs. Vanessa Uden

Dispensing Optician and Contact Lens Optician



Mr. Colin Jones Mr. Colin Jones

Dispensing Optician and Contact Lens Optician


Mrs Elizabeth RalphMrs Elizabeth Ralph

Professional Services Consultant
Contact Lens Specialist



Mr Ganeshbabu MahalingamMr Ganeshbabu Mahalingam

Optometrist and Contact Lens Specialist



Mr Mohamed Ayyaz KasmaniMr Mohamed Ayyaz Kasmani BSc(Hons) MCOptom (Feltham, London)

Optometrist and Contact Lens Specialist


Top Panel

Latest News

LATEST NEWS! This column will carry the latest news for ADP-EyeCare patients and/or prospective patients. 

18/03/2022: Andrew D Price starts meibomian gland and keratoconus screening for Nantwich patients

21/01/2022:  Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) IKERVIS 1 mg/mL eye drops, emulsion , EL (22)A/01. Go to MHRA for further information.

21/01/2022: New FAQ published on eye makeup and possible side effects here. 

14/01/2022: New video added to Dry Eye Drops - The What and The How.

29/12/2021: Mr Colin Jones joins ADP-EyeCare, added to relevant articles, also see Referral Forms and images. 

08/12/2021: A new article on Hybrid lenses added here 

18/11/2021:: : Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) and parallel distributor, IKERVIS 1 mg/mL eye drops, emulsion and VERKAZIA 1 mg/mL eye drops, emulsion, EL (21)A/30. Go to MHRA for further information. 

14/11/2021: A group educational webinar schedluled with the foremost expert on SynergEyes hybrid lenses. 

26/10/2021:: Class 3 Medicines Recall: Bimatoprost Aspire 0.3mg/ml eye drops, solution in single-dose container, Aspire Pharma Limited, EL (21)A/26. Go to MHRA for more information, 

23/10/2021: Mr Mohamed Kasmani has images added to Introduction Page. 

15/09/2021::: Class 2 Medicines Recall: Santen Oy (trading as Santen UK Ltd), Ikervis 1 mg/mL eye drops, emulsion, EL (21)A/22. Go to MHRA for more information, 

03/09/2021:: Mr Mohamed Kasmani added to Ortho-K article





A+ R A-

Dry or Watery Eyes – In-Practice/Clinic Professional Treatments

I am evaluating a number of in-practice/clinic professional treatments that may improve or replace, at least in part, home treatments, in much the same way as the treatments from your dental hygienist improve dental hygiene:



This where absorbable Intracanalicular Implants, which are microscopic plugs or implants that reduce tear flow out through the lacrimal ducts, and so retain more tears on the ocular surface, are placed in the tear ducts. The tear ducts drain tears from the eye down into the nasal pages and the back of the throat.


For dry eye patients who have difficulties producing enough tears, known as aqueous deficient dry eye, they can be particularly helpful.


One of the pathways tear loss is reduced, retaining more moisture on the eyes surface. It may mean less frequent application of drops during the day and more eye comfort on waking.
I only use absorbable Intracanicular Implants for patients nowadays, avoiding potential plug loss and discomfort, these absorb over a period of time, sometimes up to six months, rather like absorbable sutures. Implantation is painless and they are not visible to the naked eye.




Dermatologists have been using Low Level Light Therapy (LLLT) since 1987 to heal and rejuvenate tissue. Ophthalmology has been using this technology since 1999 when they started treating glaucoma via Selective Laser Trabeculoplasty (SLT), which does not cut or burn the trabecular meshwork, but simply stimulates it, increasing cellular metabolism for aqueous drainage.

Now derived from decades of use in treating gum disease this simple, innovative and professional system is used to treat many of the conditions that adversely affect the ocular surface - using Light Modulation® / LLLT technology.

Photobiomodulation treatment
Photobiomodulation treatment


Photobiomodulation is an innovative technology that stimulates mitochondria contained in the cells. Light modulation® triggers biochemical and biophysical reactions that encourages cells to create a better protein synthesis.

What are the benifits? Lower and upper eyelids treatment: 100% of the eyes’s Meibomian glands. Direct treatment of meibomian glands The LED matrix triggers eyelid endogenous heat and ATP production. This patented technology encourages removal of gland blockage, allows lipids to flow to complete tear composition. Improved lipid presence avoids fast evaporation of tears. Please contact Andrew D Price by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.  for an initial discussion on if, following an initial assessment, you may be suitable for photobiomodulation, this is provided in the practice you attend.

A treatment that has been available for some time now is the Lipiflow system. Please contact Andrew D Price by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.  for an initial discussion on if, following an initial assessment, referral for a Lipiflow treatment may be suitable for you. 



The Lipiflow System represents more than 10 years of dedicated research and is protected by more than 30 patents. Lipiflow applies simultaneous peristaltic pressure and heat to the meibomian glands. The procedure centres around the breakthrough Vector Thermal Pulse
Technology™(VTP) with heat and pressure being regulated with electronic sensors to control the exact amount of heat and pressure.


The system applies constant, controlled, directional heat to the inner surface of the eyelid while protecting the rest of the eye with an insulated shield, thus providing precise, thermally controlled, safe heat to the targeted area. This, in addition to the application of pressure, facilitates the release of secretion from the obstructed gland helping to improve the lipid layer and relieve the symptoms of dry eyes.
As a result, the obstructed meibum is liquefied and expelled out of the gland orifices. This allows the glands the ability to begin refunctioning and hopefully producing more normal meibomian oil with resultant increase in the quality of tears and a reduction of symptoms on the one hand as well as slowing or reversing the damage of obstructed permanently obstructed glands on the other hand.

Here is a video telling you more:



Right Click

No right click

Use of this website indicates the user has read, understands and accepted all the terms of use as outlined in the Disclaimer.